Literature DB >> 24866279

Relationship between the Pelvic Organ Prolapse Quantification system (POP-Q), the Pelvic Floor Impact Questionnaire (PFIQ-7), and the Pelvic Floor Distress Inventory (PFDI-20) before and after anterior vaginal wall prolapse surgery.

P Teleman1, E Laurikainen, I Kinne, R Pogosean, U Jakobsson, M Rudnicki.   

Abstract

INTRODUCTION AND HYPOTHESIS: The aim of this study was to investigate the degree of correlation between the Pelvic Organ Quantification system (POP-Q) measurements and symptom questionnaire scores before and after surgery. This was a part of a randomized controlled study comparing conventional colporrhaphy with mesh repair surgery.
METHODS: The correlation between POP-Q measurements and Pelvic Floor Impact Questionnaire (PFIQ-7) and Pelvic Floor Distress Inventory (PFDI-20) scores was investigated in 164 women 55 years or older scheduled for primary anterior vaginal wall prolapse surgery at baseline and the correlation between the change in point Ba and scores following surgery. Statistical analyses used McNemar's and Wilcoxon signed-rank tests, Spearman's rank-order correlation, and multiple linear regression.
RESULTS: Surgery significantly improved POP-Q, PFIQ-7, and PFDI-20 scores, including subscales. We observed weak correlations between POP-Q and PFIQ-7, including subscales (r 0.173-0.324, p < 0.05), and PFDI-20, including the Pelvic Organ Prolapse Distress Inventory (POPDI) subscale (r 0.180-0.211, p < 0.05). Regression analysis demonstrated a significant relationship between point Ba and PFIQ-7 (p = 0.001) and PFDI-20 (p = 0.04), respectively. Furthermore, we observed a significant relationship between the change in point Ba (following surgery) and change in scores; point Ba following surgery was significantly correlated with symptoms of bulging (r = 0.303, p < 0.01) and bladder-emptying problems (r = 0.213, p < 0.01).
CONCLUSIONS: The weak correlation between POP-Q and urogenital symptoms based on questionnaire scores suggests that neither scoring system is optimal.

Entities:  

Mesh:

Year:  2014        PMID: 24866279     DOI: 10.1007/s00192-014-2434-6

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  25 in total

1.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

2.  Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ).

Authors:  Matthew D Barber; Zhen Chen; Emily Lukacz; Alayne Markland; Clifford Wai; Linda Brubaker; Ingrid Nygaard; Alison Weidner; Nancy K Janz; Cathie Spino
Journal:  Neurourol Urodyn       Date:  2011-02-22       Impact factor: 2.696

3.  The relationship of vaginal prolapse severity to symptoms and quality of life.

Authors:  G Alessandro Digesu; Charlotte Chaliha; Stefano Salvatore; Anna Hutchings; Vik Khullar
Journal:  BJOG       Date:  2005-07       Impact factor: 6.531

4.  Vaginal wall descensus and pelvic floor symptoms in older women.

Authors:  Catherine S Bradley; Ingrid E Nygaard
Journal:  Obstet Gynecol       Date:  2005-10       Impact factor: 7.661

5.  Interobserver and intraobserver reliability of the proposed International Continence Society, Society of Gynecologic Surgeons, and American Urogynecologic Society pelvic organ prolapse classification system.

Authors:  A F Hall; J P Theofrastous; G W Cundiff; R L Harris; L F Hamilton; S E Swift; R C Bump
Journal:  Am J Obstet Gynecol       Date:  1996-12       Impact factor: 8.661

6.  Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors.

Authors:  E C Samuelsson; F T Victor; G Tibblin; K F Svärdsudd
Journal:  Am J Obstet Gynecol       Date:  1999-02       Impact factor: 8.661

Review 7.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.

Authors:  Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer
Journal:  Int Urogynecol J       Date:  2009-11-25       Impact factor: 2.894

8.  Symptoms, bother and POPQ in women referred with pelvic organ prolapse.

Authors:  Lone Mouritsen; Jens Prien Larsen
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-04-26

9.  The effect of physical activity on pelvic organ prolapse.

Authors:  N S Ali-Ross; A R B Smith; G Hosker
Journal:  BJOG       Date:  2009-05       Impact factor: 6.531

10.  Pelvic organ prolapse symptoms in relation to POPQ, ordinal stages and ultrasound prolapse assessment.

Authors:  Kirsten B Kluivers; Jan C M Hendriks; Clara Shek; Hans Peter Dietz
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-05-09
View more
  4 in total

1.  Putting POP-Q to the test: does C - D = cervical length?

Authors:  Kathryn S Williams; Lisa Rosen; Marjorie L Pilkinton; Laura Dhariwal; Harvey A Winkler
Journal:  Int Urogynecol J       Date:  2017-09-04       Impact factor: 2.894

Review 2.  Failure of Expectations in Vaginal Surgery: Lack of Appropriate Consent, Goals and Expectations of Surgery.

Authors:  Debjyoti Karmakar; Peter L Dwyer
Journal:  Curr Urol Rep       Date:  2016-12       Impact factor: 3.092

3.  Repair of recurrent rectocele with posterior colporrhaphy or non-absorbable polypropylene mesh-patient-reported outcomes at 1-year follow-up.

Authors:  Emil Nüssler; Gabriel Granåsen; Emil Karl Nüssler; Marie Bixo; Mats Löfgren
Journal:  Int Urogynecol J       Date:  2019-01-09       Impact factor: 2.894

4.  Sacrospinous ligament fixation: medium and long-term anatomical results, functional and quality of life results.

Authors:  Angeline Favre-Inhofer; Marie Carbonnel; Rouba Murtada; Aurélie Revaux; Jennifer Asmar; Jean-Marc Ayoubi
Journal:  BMC Womens Health       Date:  2021-02-12       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.